KDT VENTURES
KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector, as well as healthcare technology systems, pharmaceuticals, biotechnology, agriculture, chemicals, gases, and life sciences. The firm was founded in 2017 in Austin, Texas by Cain McClary.
KDT VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
2017-01-01
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Nginx Amazon Google Maps Google Maps API
Similar Organizations
Backstage Capital
Backstage Capital is a venture capital fund that invests in new companies led by underrepresented founders.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Advisors List
Advisor
2020-04-01
Current Employees Featured
Rima Chakrabarti Partner @ KdT Ventures
Partner
Cain McClary Founder and Managing Partner @ KdT Ventures
Founder and Managing Partner
Ally Gudeman Head of Operations @ KdT Ventures
Head of Operations
Isaac B. Stoner Advisor & LP @ KdT Ventures
Advisor & LP
2017-05-01
Phil Grayeski Principal @ KdT Ventures
Principal
Mack Healy Managing Partner @ KdT Ventures
Managing Partner
Founder
Investors List
Bienville Capital
Bienville Capital investment in Seed Round - KdT Ventures
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-01 | Canaery | KdT Ventures investment in Seed Round - Canaery | 4 M USD |
2022-06-30 | Faeth Therapeutics | KdT Ventures investment in Series A - Faeth Therapeutics | 47 M USD |
2022-06-15 | Molecule | KdT Ventures investment in Seed Round - Molecule | 13 M USD |
2022-02-15 | Terray Therapeutics | KdT Ventures investment in Series A - Terray Therapeutics | 60 M USD |
2022-02-01 | Marigold Health | KdT Ventures investment in Seed Round - Marigold Health | 6 M USD |
2022-01-18 | Faeth Therapeutics | KdT Ventures investment in Seed Round - Faeth Therapeutics | 20 M USD |
2021-12-16 | Greeneye Technology | KdT Ventures investment in Series A - Greeneye Technology | 22 M USD |
2021-12-08 | Zymochem | KdT Ventures investment in Seed Round - Zymochem | 4 M USD |
2021-11-03 | Parthenon Therapeutics | KdT Ventures investment in Series A - Parthenon Therapeutics | 65 M USD |
2021-09-16 | 54gene | KdT Ventures investment in Series B - 54gene | 25 M USD |
More informations about "KdT Ventures"
KdT Ventures - Crunchbase Investor Profile
KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector, as well as healthcare technology systems, pharmaceuticals, biotechnology, agriculture, chemicals, gases, and life …See details»
KdT Ventures - Investments, Portfolio & Company Exits - Crunchbase
KdT Ventures 's most notable exits include Tavros Therapeutics, Azitra, and PathAI. Which industries has this organization had the most exits in? Show . Tavros Therapeutics Tavros …See details»
List of top KdT Ventures Portfolio Companies - Crunchbase
Mar 26, 2018 KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector. This list of organizations invested in by KdT Ventures …See details»
KdT Ventures Closes $100M Fund IV to Fuel Early-Stage Science …
Oct 17, 2024 KdT Ventures has announced the successful close of its oversubscribed fourth fund (Fund IV), raising over $100 million to support early-stage, science-driven companies. …See details»
KdT Ventures - Overview, News & Similar companies - ZoomInfo
KdT Ventures, which focuses on funding companies in frontier science fields, has raised $50 million in its second fund, with the goal of investing in about 25 companies around the country. …See details»
KdT Ventures Closes Fund IV, at Over $250M - vcwire.tech
Oct 17, 2024 KdT Ventures, an Austin, Texas-based venture capital firm backing frontier science companies, closed its fourth fund, at over $100m.. The fund, the firm’s largest fund to date, …See details»
Fundopedia | KdT Ventures
KdT Ventures is an early-stage venture capital firm that invests in frontier science companies, helping founders re-architect the world at a molecular level.See details»
KdT Ventures
KdT Ventures, founded in 2017 by Cain McClary, is a venture capital firm focused on earlystage frontier science investing. The firm believes in the potential of reprogramming chemistry and …See details»
KdT Ventures Closes Oversubscribed Fourth Fund at $100 Million …
Oct 16, 2024 KdT Ventures has successfully closed its fourth fund, raising over $100 million to back early-stage, science-driven companies. This Fund IV is the firm’s largest fund to date, …See details»
KdT Ventures Investments, Portfolio & Acquisitions | Messari
Jun 12, 2022 Explore KdT Ventures investment data including portfolio, fundraising, and acquisitions.See details»
KdT Ventures Announces Oversubscribed Fund IV to Invest in Early …
AUSTIN, Texas, October 16, 2024--(BUSINESS WIRE)--KdT Ventures today announced the successful close of its oversubscribed fourth fund (Fund IV), raising over $100 million to …See details»
KdT Ventures Closes on $100M Fund IV, Makes Two Promotions
Oct 16, 2024 The oversubscribed KdT Ventures Fund IV surpassed its predecessor fund, which launched in 2022 and raised $80M on its final close. Fund IV aims to deploy seed investments, …See details»
KdT Ventures - Funding, Financials, Valuation & Investors
KdT Ventures has raised 5 funds, their latest being KdT Ventures Fund IV. This fund was announced on Oct 16, 2024 and raised a total of . obfuscated. obfuscated. Announced Date . …See details»
NGM Bio and KdT Ventures Enter into Worldwide License …
Dec 19, 2024 KdT Ventures has formed a new company (NewCo) to develop NGM313 in a rare disease, representing the first non-metabolic indication for which NGM313 will be evaluated. …See details»
Life sciences investor KdT Ventures raises $100M fourth fund
Oct 16, 2024 Life sciences VC shop KdT Ventures disclosed its $100 million fourth fund on Wednesday morning, just over two years after announcing an $80 million fund. The seven …See details»
KdT Ventures tops $100m for fourth fund
Oct 16, 2024 KdT Ventures, which invests in early-stage science-driven start-ups, has closed its oversubscribed fourth fund at more than $100 million. Fund IV is the 7-year-old firm’s largest …See details»
A venture firm breathes new life into an old NGM drug
Dec 19, 2024 KdT Ventures is launching a new biotechnology startup based on a drug it’s licensing from NGM Biopharmaceuticals, the companies announced Thursday. The deal …See details»
KdT Ventures - Contacts, Employees, Board Members
KdT Ventures has 6 current employee profiles, including Partner Rima Chakrabarti. KdT Ventures has 1 board member or advisor, Alasdair Thong. Contacts. Edit Contacts Section. Job …See details»
Cain McClary - Managing Partner & Founder at KdT Ventures
Cain McClary, MD is the founder and Managing Partner of KdT Ventures. A native of Nashville, TN, Cain received his Sc.B. in Biochemistry and Molecular Biology from Brown University in …See details»
The World In A Grain of Sand by KdT Ventures | Patrick Malone
May 29, 2024 KdT is the standard in early-stage science-driven venture capital. We help founders and their companies re-architect the world at a molecular level. Click to read The …See details»